We are live on ! Find out more
RPTP

RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP

Delisted

RPTP was delisted on the 24th of October, 2016.

74 hedge funds and large institutions have $359M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 20

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

17% more capital invested

Capital invested by funds: $308M → $359M (+$51.7M)

4% more funds holding

Funds holding: 7174 (+3)

9% less call options, than puts

Call options by funds: $19.1M | Put options by funds: $20.9M

Holders
74
Holders Change
+3
Holders Change %
+4.23%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
28
Reduced
20
Closed
11
Calls
$19.1M
Puts
$20.9M
Net Calls
-$1.84M
Net Calls Change
+$6.12M
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$1.32M +$53.7K +5,900 +5%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$1.31M
AllianceBernstein
28
AllianceBernstein
Tennessee
$1.27M -$2.16K -237 -0.2%
TA
29
Teachers Advisors
New York
$1.01M +$5.84K +641 +0.7%
Citadel Advisors
30
Citadel Advisors
Florida
$849K -$133K -14,578 -17%
Swiss National Bank
31
Swiss National Bank
Switzerland
$840K
ProShare Advisors
32
ProShare Advisors
Maryland
$792K -$353K -38,781 -36%
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$629K +$24.1K +2,646 +5%
State Board of Administration of Florida Retirement System
34
State Board of Administration of Florida Retirement System
Florida
$624K +$6.52K +716 +1%
AQR Capital Management
35
AQR Capital Management
Connecticut
$580K -$307K -33,700 -40%
MLICM
36
Metropolitan Life Insurance Company (MetLife)
New York
$561K
NFA
37
Nationwide Fund Advisors
Ohio
$555K +$19.4K +2,126 +5%
VOYA Investment Management
38
VOYA Investment Management
Georgia
$550K
AIG
39
American International Group
New York
$473K +$3.6K +395 +1%
EAM
40
Eventide Asset Management
Massachusetts
$467K
Millennium Management
41
Millennium Management
New York
$467K +$369K +40,473 New
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$466K -$47K -5,166 -11%
BA
43
BlackRock Advisors
Delaware
$458K -$42.9K -4,707 -11%
BKBG
44
BHF Kleinwort Benson Group
Belgium
$454K
DekaBank Deutsche Girozentrale
45
DekaBank Deutsche Girozentrale
Germany
$412K -$4.55K -500 -1%
CLOS
46
Compagnie Lombard Odier SCmA
Switzerland
$393K +$91.1K +10,000 +42%
American Century Companies
47
American Century Companies
Missouri
$368K +$290K +31,835 New
Bank of America
48
Bank of America
North Carolina
$357K +$60K +6,585 +27%
T. Rowe Price Associates
49
T. Rowe Price Associates
Maryland
$312K -$41K -4,500 -14%
UBS AM
50
UBS AM
Illinois
$294K

RPTP Hedge Fund Activity: Q2 2014 in Review

74 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q2 2014, worth a combined $359M — up 17% from $308M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new RPTP positions and 11 closed out — a net gain of 3 holders — while 28 added to existing stakes and 20 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $9.78M. The largest seller was Assured Investment Management, exiting entirely with an estimated $9.89M sold.

  • 74 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q2 2014, up from 71 in Q1 2014.
  • Funds reported $359M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q2 2014, up 17% quarter-over-quarter.
  • 14 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q2 2014 and 11 closed out, a net change of +3 holders.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q2 2014 was Goldman Sachs, an estimated $9.78M added.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q2 2014 was Assured Investment Management, an estimated $9.89M sold.

Based on aggregated 13F filings for Q2 2014.